Financing includes $63.5M Series B equity and $20M strategic non-dilutive credit facilityCapital supports accelerated scaling amid strong ...

(MENAFN- GlobeNewsWire - Nasdaq) Key cancer diagnostics market opportunities include: early detection technologies like liquid biopsy and AI imaging, precision medicine boosting demand for molecular ...

Particles in the size-range of one to 100 nanometres called nanoparticles exhibit significantly different physical and chemical properties owing to their large surface area to volume ratio.

Biocerta Precision Diagnostics, Inc., a biotechnology company pioneering functional drug sensitivity testing (DST) to personalize cancer therapy, today announced two major business milestones: (1) an ...

The global companion diagnostics market is projected to grow at a robust CAGR of approximately 13% through 2031. This growth is driven by the increasing demand for personalized medicine, continuous ...